110 related articles for article (PubMed ID: 11750655)
1. Inhibition of class II trans-activator function by HIV-1 tat in mouse cells is independent of competition for binding to cyclin T1.
Mudhasani R; Fontes JD
Mol Immunol; 2002 Jan; 38(7):539-46. PubMed ID: 11750655
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
[TBL] [Abstract][Full Text] [Related]
3. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
Kanazawa S; Okamoto T; Peterlin BM
Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
[TBL] [Abstract][Full Text] [Related]
4. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
5. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
6. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
7. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
[TBL] [Abstract][Full Text] [Related]
8. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
[TBL] [Abstract][Full Text] [Related]
9. Granulin and granulin repeats interact with the Tat.P-TEFb complex and inhibit Tat transactivation.
Hoque M; Tian B; Mathews MB; Pe'ery T
J Biol Chem; 2005 Apr; 280(14):13648-57. PubMed ID: 15653695
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
12. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation.
Kwak YT; Ivanov D; Guo J; Nee E; Gaynor RB
J Mol Biol; 1999 Apr; 288(1):57-69. PubMed ID: 10329126
[TBL] [Abstract][Full Text] [Related]
13. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
14. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
Kanazawa S; Peterlin BM
Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
[TBL] [Abstract][Full Text] [Related]
15. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
17. Functional differences between human and bovine immunodeficiency virus Tat transcription factors.
Bogerd HP; Wiegand HL; Bieniasz PD; Cullen BR
J Virol; 2000 May; 74(10):4666-71. PubMed ID: 10775603
[TBL] [Abstract][Full Text] [Related]
18. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
Liou LY; Herrmann CH; Rice AP
J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
[TBL] [Abstract][Full Text] [Related]
19. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
20. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]